ERElaine Ron

Elaine Ron

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elaine Ron has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Alexander V. Akleyev

    1 shared publication
  • Alina Brenner

    1 shared publication
  • Dale L. Preston

    Affiliations of authors: Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NationalInstitute of Health, Department of Health andHuman Services, Bethesda, MD (ER); Radiation Effects Research Foundation, Nagasaki, Japan (TI); Department of Statistics, Radiation Effects Research Foundation, Hiroshima, Japan (DLP), Radiation Effects Research Foundation, Hiroshima, Japan (ST)

    1 shared publication
  • Dale L. Preston

    Department of Statistics, Radiation Effects Research Foundation, Hiroshima, Japan

    1 shared publication
  • Evgenia V. Ostroumova

    1 shared publication
  • Gabriel Chodick

    Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892-7238, USA

    1 shared publication

Latest Publications

  • Non-malignant Thyroid Diseases after a Wide Range of Radiation Exposures

    by Elaine Ron, Alina Brenner

    The thyroid gland is one of the most radiosensitive human organs. While it is well known that radiation exposure increases the risk of thyroid cancer, less is known about its effects in relation to non-malignant thyroid diseases. The aim of this review is to evaluate the effects of high- and low-dose radiation on benign structural and functional diseases of the thyroid. We examined the results of major studies from cancer patients treated with high-dose radiotherapy or thyrotoxicosis patients treated with high doses of iodine-131, patients treated with moderate- to high-dose radiotherapy for benign diseases, persons exposed to low doses from environmental radiation, and survivors of the atomic bombings who were exposed to a range of doses. We evaluated radiation effects on structural (tumors, nodules), functional (hyper- and hypothyroidism), and autoimmune thyroid diseases. After a wide range of doses of ionizing radiation, an increased risk of thyroid adenomas and nodules was observed in a variety of populations and settings. The dose response appeared to be linear at low to moderate doses, but in one study there was some suggestion of a reduction in risk above 5 Gy. The elevated risk for benign tumors continues for decades after exposure. Considerably less consistent findings are available regarding functional thyroid diseases including autoimmune diseases. In general, associations for these outcomes were fairly weak, and significant radiation effects were most often observed after high doses, particularly for hypothyroidism. A significant radiation dose–response relationship was demonstrated for benign nodules and follicular adenomas. The effects of radiation on functional thyroid diseases are less clear, partly due to the greater difficulties encountered in studying these diseases.


    • 1 December 2009
      • Vol. 7  (2) , 29-36

    Radiation risks from pediatric computed tomography scanning.

    by Gabriel Chodick, Kwang Pyo Kim, Michael Shwarz, Gad Horev, Varda Shalev, Elaine Ron

    Although radiological exams are not frequently used to diagnose unsuspected endocrine disease, computed tomography (CT) plays a significant role in today's endocrinology. Despite the known association between radiation exposure during childhood and cancer, the use of pediatric CT, which delivers non-negligible radiation doses to some organs and tissues, continues to rise sharply. The purpose of this review is to describe the current use of pediatric CT, explain basic concepts in ionizing radiation physics and dosimetry, and discuss potential risks from pediatric CT scans. Finally, we will summarize two recent programs for reducing and controlling exposure to ionizing radiation from pediatric CT: the As Low As Reasonably Achievable (ALARA) concept and the Image Gently initiative. Promoting public awareness and particularly educating referring physicians, including endocrinologists, about the potential radiation-associated risks from CT scans, is essential for reducing unnecessary radiation exposure from CT in children.


  • THYROID CANCER INCIDENCE AMONG PEOPLE LIVING IN AREAS CONTAMINATED BY RADIATION FROM THE CHERNOBYL ACCIDENT

    by Elaine Ron

    As a result of the Chernobyl nuclear power plant accident, massive amounts of radioactive materials were released into the environment and large numbers of individuals living in Belarus, Russia, and Ukraine were exposed to radioactive iodines, primarily 131I. Iodine-131 concentrated in the thyroid gland of residents of the contaminated areas, with children and adolescents being particularly affected. In the decade after the accident, a substantial increase in thyroid cancer incidence was observed among exposed children in the three affected countries, and compelling evidence of an association between pediatric thyroid cancer incidence and radiation exposure to the thyroid gland accumulated. The data currently available suggest that both the magnitude and patterns of thyroid cancer risk are generally consistent with those reported following external exposure. Based on data from case-control studies, iodine deficiency appeared to enhance the risk of developing thyroid cancer following exposure from Chernobyl. Results from a recent large cohort study, however, did not support these findings. Data on adult exposure are limited and not entirely consistent. Similarly, information on thyroid cancer risks associated with in utero exposure is insufficient to draw conclusions. The lack of information on these two population groups indicates an important gap that needs to be filled. Twenty years after the accident, excess thyroid cancers are still occurring among persons exposed as children or adolescents, and, if external radiation can be used as a guide, we can expect an excess of radiation-associated thyroid cancers for several more decades. Since considerable uncertainties about the long-term health effects from Chernobyl remain, continued follow-up of the exposed populations should provide valuable information.


  • Reply to Comments on “Protracted Radiation Exposure and Cancer Mortality in the Techa River Cohort” by Krestininaet al

    by Ludmila Yu Krestinina, Dale L. Preston, Evgenia V. Ostroumova, Marina O. Degteva, Elaine Ron, Olga V. Vyushkova, Nicholas V. Startsev, Alexander V. Akleyev


  • Open Access

    Childhood Cancer—Treatment at a Cost

    by Elaine Ron

    Over the last 30 years, more effective treatments, as well as enhanced methods for early diagnosis of cancer have resulted in major improvements in survival for childhood malignancies. The relative 5-year survival rate has risen from 56% for children diagnosed between 1974 and 1976 to 79% for those diagnosed in the period 1995–2001 ( 1 ) , and the current 10-year survival rate is approximately 75% ( 2 ) . This increased survival means that the majority of children with cancer can look forward to a long life; however, they may experience multiple late health problems. One of the most alarming long-term consequences of childhood cancer is the occurrence of a second primary malignancy. Although the etiology of many second cancers is unknown, treatment-related cancers are a well-recognized sequela of both radiotherapy and chemotherapy ( 3 , 4 ) . An excess risk of subsequent malignancies of the thyroid, breast, bone, soft tissue, and central nervous system (CNS) following radiation treatment for childhood cancer have been reported, whereas secondary leukemia is the main malignancy associated with chemotherapy ( 5 , 6 ) .


  • Open Access

    Male Breast Cancer Incidence Among Atomic Bomb Survivors

    by Elaine Ron, Takayoshi Ikeda, Dale L. Preston, Shoji Tokuoka

    To learn more about the role of ionizing radiation in the development of male breast cancer, we evaluated male breast cancer incidence among 45 880 male members of the Life Span Study cohort of Japanese atomic bomb survivors. Male breast cancers, diagnosed between January 1, 1958, and December 31, 1998, were identified through the Hiroshima and Nagasaki Tumor Registries. Nine male breast cancers were diagnosed among exposed Life Span Study members (crude rate = 1.8 per 100 000 person-years), and three were diagnosed among nonexposed cohort members (crude rate = 0.5 per 100 000 person-years). A statistically significant dose–response relation was observed (excess relative risk per sievert = 8, 95% confidence interval = 0.8 to 48; P = .01). Our finding of a statistically significant association between ionizing radiation and male breast cancer incidence adds to the very limited information that shows an association between radiation exposure and an increased risk of male breast cancer.


  • Top Cited Papers

    CANCER RISKS FROM MEDICAL RADIATION

    by Elaine Ron

    About 15% of the ionizing radiation exposure to the general public comes from artificial sources, and almost all of this exposure is due to medical radiation, largely from diagnostic procedures. Of the approximately 3 mSv annual global per caput effective dose estimated for the year 2000, 2.4 mSv is from natural background and 0.4 mSv from diagnostic medical exams. Diagnostic and therapeutic radiation was used in patients as early as 1896. Since then, continual improvements in diagnostic imaging and radiotherapy as well as the aging of our population have led to greater use of medical radiation. Temporal trends indicate that worldwide population exposure from medical radiation is increasing. In the United States, there has been a steady rise in the use of diagnostic radiologic procedures, especially x rays. Radiotherapy also has increased so that today about 40% of cancer patients receive some treatment with radiation. Epidemiologic data on medically irradiated populations are an important complement to the atomic-bomb survivors’ studies. Significant improvement in cancer treatment over the last few decades has resulted in longer survival and a growing number of radiation-related second cancers. Following high-dose radiotherapy for malignant diseases, elevated risks of a variety of radiation-related second cancers have been observed. Risks have been particularly high following treatment for childhood cancer. Radiation treatment for benign disease was relatively common from the 1940’s to the 1960’s. While these treatments generally were effective, some resulted in enhanced cancer risks. As more was learned about radiation-associated cancer risks and new treatments became available, the use of radiotherapy for benign disease has declined. At moderate doses, such as those used to treat benign diseases, radiation-related cancers occur in or near the radiation field. Cancers of the thyroid, salivary gland, central nervous system, skin, and breast as well as leukemia have been associated with radiotherapy for tinea capitis, enlarged tonsils or thymus gland, other benign conditions of the head and neck, or benign breast diseases. Because doses from diagnostic examinations typically are low, they are difficult to study using epidemiologic methods, unless multiple examinations are performed. An excess risk of breast cancer has been reported among women with tuberculosis who had multiple chest fluoroscopies as well as among scoliosis patients who had frequent diagnostic x rays during late childhood and adolescence. Dental and medical diagnostic x rays performed many years ago, when doses were presumed to be high, also have been linked to increased cancer risks. The carcinogenic effects of diagnostic and therapeutic radionuclides are less well characterized. High risks of liver cancer and leukemia have been demonstrated following thorotrast injections, and patients treated with radium appear to have an elevated risk of bone sarcomas and possibly cancers of the breast, liver, kidney, thyroid, and bladder.